Ranger Investment Management L.P. cut its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 22.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 702,300 shares of the technology company's stock after selling 199,695 shares during the quarter. Ranger Investment Management L.P. owned approximately 3.50% of Simulations Plus worth $19,587,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in SLP. BNP Paribas Financial Markets grew its stake in Simulations Plus by 402.9% in the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company's stock worth $1,279,000 after purchasing an additional 32,002 shares in the last quarter. Verition Fund Management LLC boosted its holdings in Simulations Plus by 120.5% in the third quarter. Verition Fund Management LLC now owns 10,365 shares of the technology company's stock worth $332,000 after purchasing an additional 5,665 shares during the period. State Street Corp boosted its holdings in shares of Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company's stock valued at $20,503,000 after buying an additional 28,953 shares during the period. First National Bank of Omaha raised its stake in Simulations Plus by 56.1% during the third quarter. First National Bank of Omaha now owns 9,704 shares of the technology company's stock worth $311,000 after acquiring an additional 3,488 shares during the period. Finally, Barclays PLC boosted its stake in Simulations Plus by 390.6% in the third quarter. Barclays PLC now owns 28,473 shares of the technology company's stock valued at $911,000 after acquiring an additional 22,669 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.
Simulations Plus Trading Up 2.0 %
NASDAQ:SLP traded up $0.66 during mid-day trading on Monday, hitting $33.31. The company's stock had a trading volume of 426,575 shares, compared to its average volume of 186,782. Simulations Plus, Inc. has a fifty-two week low of $23.01 and a fifty-two week high of $51.22. The company has a market capitalization of $669.90 million, a price-to-earnings ratio of 83.28 and a beta of 1.13. The stock has a fifty day moving average of $28.88 and a 200-day moving average of $30.02.
Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.25 by $0.06. The company had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 EPS. On average, equities analysts anticipate that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts have commented on SLP shares. KeyCorp upped their target price on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. StockNews.com upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research note on Friday, April 4th. Finally, William Blair reissued an "outperform" rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $49.40.
Get Our Latest Stock Analysis on Simulations Plus
Insider Activity
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is currently owned by corporate insiders.
Simulations Plus Company Profile
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.